2004 Update of dosimetry for the Utah Thyroid Cohort Study

Radiation Research

Volumn 165, Issue 2, 2006, Pages 208-222

  Simon, Steven L ^a   Anspaugh, Lynn R ^b   Hoffman, F Owen ^d   Scholl, Alan E ^c   Stone, Mary B ^c   Thomas, Brian A ^d   Lyon, Joseph L ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d SENES Oak Ridge Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; COMPUTER PROGRAM; DATA BASE; DOSIMETRY; FALLOUT; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RISK ASSESSMENT; SCHOOL CHILD; THYROID DISEASE; THYROID GLAND; UNITED STATES;

BODY BURDEN; CLINICAL TRIALS; COHORT STUDIES; COMPUTER SIMULATION; ENVIRONMENTAL EXPOSURE; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RADIOACTIVE FALLOUT; RADIOMETRY; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK ASSESSMENT; THYROID NEOPLASMS; UTAH;

EID: 31444448045     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3483.1     Document Type: Article

References (84)

1. U.S. Congress. The Nature of Radioactive Fallout and its Effects on Man. Hearings before the Special Subcommittee on Radiation, Joint Committee on Atomic Energy. 85th Congress, U.S. Government Printing Oflice. Washington, DC, 1957.
2. U.S. Congress. Fallout from Nuclear Weapons Tests. Hearings before the Special Subcommittee on Radiation. Joint Committee on Atomic Energy. 86th Congress. U.S. Government Printing Office. Washington, DC, 1959.
3. J. U.S. Congress, Fallout. Radiation Standards, and Countermeasures. Hearings before the Subcommittee on Research, Development and Radiation. Joint Committee on Atomic Energy, 88th Congress, U.S. Government Printing Office, Washington, DC, 1963.
4. E. S. Weiss, M. L. Rallison, W. T. London and G. D. C. Thompson, Thyroid nodularity in southwestern Utah children exposed to fallout radiation. Am. J. Public Health 61, 241-249 (1971).
5. E. S. Weiss, R. E. Olsen, G. D. C. Thompson and A. T. Masi, Surgically treated thyroid disease among young people in Utah, 1948-1962. Am. J. Public Health 57, 1807-1814 (1967).
6. J. L. Lyon, M. Klauber, J. W. Gardner and K. S. Udall, Childhood leukemias associated with fallout from nuclear tests. New Engl. J. Med. 300, 397-402 (1979).
7. D. C. Gren, H. A. Hawthorne, R. D. Lloyd, S. L. Simon, J. E. Till, R. A. Crockett and W. Stevens, Feeding of Dairy Livestock and Milk Distribution for the Thyroid Cohort Study. University of Utah Department of Family and Preventive Medicine, Salt Lake City, 1988.
8. S. L. Simon, R. D. Lloyd, J. E. Till, H. W. Hawthorne, D. C. Gren, M. L. Rallison and W. Stevens, Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study. Health Phys. 59, 669-691 (1990).
9. J. E. Till, S. L. Simon, R. Kerber, R. D. Lloyd, W. Stevens, D. C. Thomas, J. L. Lyon and S. Preston-Martin, The Utah Thyroid Cohort Study: Analysis of the dosimetry results. Health Phys. 68, 472-483 (1995).
10. R. A. Kerber, J. E. Till, S. L. Simon, J. L. Lyon, D. C. Thomas, S. Preston-Martin, M. L. Rallison, R. D. Lloyd and W. Stevens, A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. J. Am. Med. Assoc. 270, 2076-2082 (1993).
11. U.S. National Cancer Institute, Estimated Exposures and Thyroid Doses Received by the American People from Iodine-131 in Fallout following Nevada Atmospheric Nuclear Bomb Tests. U.S. National Cancer Institute, Bethesda, MD, 1997.
12. U.S. Congress, National Cancer Institute's Management of Radiation Studies. Hearings before the Permanent Subcommittee on Investigations of the Committee on Governmental Affairs, U.S. Senate, 105th Congress, U.S. Government Printing Office, Washington, DC, 1998.
13. U.S. Congress, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriation Bill, 1999. Senate Appropriations Bill Report 105-300, U.S. Senate, 105th Congress, U.S. Government Printing Office, Washington, DC, 1998.
14. W. Stevens, J. E. Till, D. C. Thomas, J. L. Lyon, R. A. Kerber, S. Preston-Martin, S. L. Simon, M. L. Rallison and R. D. Lloyd, Report of a Cohort Study of Thyroid Disease and Radioactive Fallout from the Nevada Test Site. University of Utah Department of Family and Preventive Medicine, Salt Lake City, 1992.
15. H. A. Knapp, Iodine-131 in Fresh Milk and Human Thyroids Following a Single Deposition of Nuclear Test Fallout. TID-19266, U.S. Atomic Energy Commission, Division of Biology and Medicine, Fallout Studies Branch, Washington, DC, 1963.
16. B. W. Church, D. L. Wheeler, C. M. Campbell, R. V. Nutley and L. R. Anspaugh, Overview of the Department of Energy's Off-Site Radiation Exposure Review Project (ORERP). Health Phys. 59, 503-510 (1990).
17. H. L. Beck, Exposure Rate Conversion Factors for Radionuclides Deposited on the Ground. EML-378, U.S. Department of Energy, Environmental Measurements Laboratory, New York, 1980.
18. H. G. Hicks, Calculation of the concentration of any radionuclide deposited on the ground by off-site fallout from a nuclear detonation. Health Phys. 42, 585-600 (1982).
19. H. L. Beck, Estimates of Fallout from Nevada Weapons Testing in the Western United Stales Based on Gummed Film Monitoring Data. EML-433, U.S. Department of Energy, Environmental Measurements Laboratory, New York, 1984.
20. F. W. Whicker and T. Kirchner, PATHWAY: A dynamic food chain model to predict radionuclide ingestion after fallout deposition. Health Phys. 52, 717-737 (1987).
21. D. D. Breshears, T. B. Kirchner, M. O. Otis and F. W. Whicker, Uncertainty in predictions of fallout radionuclides in foods and of subsequent ingestion. Health Phys. 57, 943-953 (1989).
22. R. W. Henderson and R. F. Smale, External exposure estimates for individuals near the Nevada Test Site. Health Phys. 59, 715-721 (1990).
23. H. G. Hicks, Additional calculations of radionuclide production following nuclear explosions and Pu isotopic ratios for Nevada Test Site events. Health Phys. 59, 515-523 (1990).
24. Y. C. Ng, L. R. Anspaugh and R. T. Cederwall, ORERP internal dose estimates for individuals. Health Phys. 59, 693-713 (1990).
25. V. E. Quinn, Analysis of meteorological and radiological data for selected fallout episodes. Health Phys. 59, 577-592 (1990).
26. G. M. Ward and F. W. Whicker, Milk distribution and feeding practice data for the PATHWAY model. Health Phys. 59, 637-43 (1990).
27. F. W. Whicker, T. B. Kirchner, D. D. Breshears and M. D. Otis, Estimation of radionuclide ingestion: The "PATHWAY" food-chain model. Health Phys. 59, 645-657 (1990).
28. C. B. Thompson, Estimates of exposure rates and fallout arrival times near the Nevada Test Site. Health Phys. 59, 555-563 (1990).
29. H. L. Beck and L. R. Anspaugh, Development of the County Data Base: Estimates of Exposure Rates and Times of Arrival of Fallout in the ORERP Phase-II Area. Comparison with Cumulative Deposition Estimates Based on Analyses of Retrospective and Historical Soil Samples. Report NVO-320, U.S. Department of Energy, Nevada Operations Office, Las Vegas, 1991.
30. C. B. Thompson, R. D. McArthur and S. W. Hutchinson, Development of the Town Data Base: Estimates of Exposure Rates and Times of Fallout Arrival near the Nevada Test Site. Report DOE/NV-374, U.S. Department of Energy, Nevada Operations Office, Las Vegas, 1994.
31. L. R. Anspaugh and B. W. Church, Historical estimates of external 7 exposure and collective external γ exposure from testing at the Nevada Test Site. 1. Test series through Hardtack 11, 1958. Health Phys. 51, 35-51 (1986).
32. L. R. Anspaugh, Y. E. Ricker, S. C. Black, R. F. Grossman, D. L. Wheeler, B. W. Church and V. E. Quinn, Historical estimates of external 7 exposure and collective external 7 exposure from testing at the Nevada Test Site. II. Test series after Hardtack 11, 1958, and summary. Health Phys. 59, 525-532 (1990).
33. NCRR SI Units in Radiation Protection and Measurements. Report No. 82, National Council on Radiation Protection and Measurements, Bethesda, MD, 1985.
34. G. D. Potter, Film badge and survey-meter databases for historical off-site radiation exposures around the Nevada Test Site. Health Phys. 50, 424 (1986).
35. R. F. Grossman and C. B. Thompson, Creation of a Database of Survey Meter Readings in the Western United States after Nuclear Tests. Report EPA/600/R-93/034, U.S. Environmental Protection Agency, Las Vegas, 1993.
36. H. G. Hicks, Radiochemical Data Collected on Events from which Radioactivity Escaped Beyond the Borders of the Nevada Test Range Complex. Report UCRL-52934, University of California, Lawrence Livermore Laboratory, Livermore, 1981.
37. H. G. Hicks, Results of Calculations of External Gamma Radiation Exposure Rates from Fallout and the Related Radionuclide Compositions, Parts 1-8. Report UCRL-53152, University of California, Lawrence Livermore Laboratory, Livermore, 1981.
38. Radiation Shielding Information Center, RSIC Computer Code Collection. ORIGEN-79 Isotope Generation and Depletion Code-Matrix Exponential Method. Report CCC-217, Oak Ridge National Laboratory, Oak Ridge, 1979.
39. 239+240Pu from Nevada Test Site Detonations. Report EML-400, U.S. Environmental Measurements Laboratory, New York, 1981.
40. R. T. Cederwall and K. R. Peterson, Meteorological modeling of arrival and deposition of fallout at intermediate distances downwind of the Nevada Test Site. Health Phys. 59, 593-601 (1990).
41. S. L. Simon, An analysis of vegetation interception data pertaining to close-in weapons test fallout. Health Phys. 59, 619-626 (1990).
42. U.S. National Cancer Institute, Individual Dose Calculator. U.S. National Cancer Institute, Bethesda, http://ntsi131.nci.nih.gov/, last accessed on February 6, 2005.
43. E. M. Rupp, Age dependent values of dietary intake for assessing human exposure to environmental pollutants. Health Phys. 39, 151-163 (1980).
44. Y. C. Ng, C. S. Colsher, D. J. Quinn and S. E. Thompson, Transfer Coefficients for the Prediction of the Dose to Man Via the Forage-Cow-Milk Pathway from Radionuclides Released to the Biosphere. Report UCRL-51939, University of California, Lawrence Livermore Laboratory, Livermore, 1977.
45. 131I into human breast milk and transfer coefficients for radiological dose assessments. Health Phys. 82, 796-806 (2002).
46. K. J. Kopecky, S. Davis, T. E. Hamilton, M. S. Saporito and L. E. Onstad, Estimation of thyroid radiation doses for the Hanford Thyroid disease study: Results and implications for statistical power of the epidemiological analyses. Health Phys. 87, 15-32 (2004).
47. U.S. Centers for Disease Control and Prevention and U.S. National Cancer Institute, A Feasibility Study of the Health Consequences to the American Population from Nuclear Weapons Tests Conducted by the United States and other Nations. U.S. Centers for Disease Control and Prevention, Atlanta, in press.
48. D. J. Brenner, The relative effectiveness of exposure to I-131 at low doses. Health Phys. 76, 180-185 (1999).
49. S. Davis, V. Stepanenko, N. Rivkind, K. J. Kopecky, P. Voilleque, V. Shakhtarin, E. Parshkov, S. Kulikov, E. Lushnikov and A. Tsyb, Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat. Res. 162, 241-248 (2004).
50. S. Davis, K. J. Kopecky, T. E. Hamilton and L. Onstad, Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford Nuclear Site. J. Am. Med. Assoc. 292, 2600-2613 (2004).
51. J. A. Franklyn, P. Maisonneuve, M. Sheppard, J. Betteridge and P. Boyle, Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study. Lancet 353, 2111-2115 (1999).
52. K. Hahn, P. Schnell-Inderst, B. Grosche and L. E. Holm, Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat. Res. 156, 61-70 (2001).
53. P. Hall, C. J. Furst, A. Mattsson, L. E. Holm, J. D. Boice, Jr. and P. D. Inskip, Thyroid nodularity after diagnostic administration of iodine-131. Radiat. Res. 146, 673-682 (1996).
54. P. Hall, A. Mattsson and J. D. Boice, Thyroid cancer after diagnostic administration of iodine-131. Radiat. Res. 145, 86-92 (1996).
55. P. Jacob, Y. Kenigsberg, I. Zvonova, G. Goulko, E. Buglova, W. F. Heidenreich, A. Golovneva, A. A. Bratilova, V. Drozdovitch and H. G. Paretzke, Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br. J. Cancer 80, 1461-1469 (1999).
56. J. Robbins, Lessons from Chernobyl: The event, the aftermath fall-out: Radioactive, political, social. Thyroid 7, 189-192 (1997).
57. M. Schlumberger and F. DeVathaire, 131 iodine: Medical use. Carcinogenetic and genetic effects. Ann. Endocrinol. Paris 57, 166-176 (1996).
58. V. A. Stezhko, E. E. Buglova, L. I. Danilova, V. M. Drozd, N. A. Krysenko, N. R. Lesnikova, V. F. Minenko, V. A. Ostapenko, S. V. Petrenko and L. B. Zablotska, A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: Objectives, design and methods. Radiat. Res. 161, 481-492 (2004).
59. C. M. Grossman, R. H. Nussbaum and F. D. Nussbaum, Cancers among residents downwind of the Hanford, Washington, plutonium production site. Arch. Environ. Health 58, 267-274 (2003).
60. W. M. Bice-Stephens, Radiation injuries from military and accidental explosions: A brief historical review. Mil. Med. 165, 275-277 (2000).
61. M. I. Boutte, Compensating for health: The acts and outcomes of atomic testing. Hum. Organ. 61, 41-50 (2002).
62. F. de Vathaire, B. Le Vu and C. Challeton-de Vathaire, Thyroid cancer in French Polynesia between 1985 and 1995: Influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1996 and 1974. Cancer Causes Control 11, 59-63 (2000).
63. H. J. Dworkin, Nuclear-weapons testing fallout and thyroid-disease. J. Am. Med. Assoc. 271, 825-826 (1994).
64. E. Frohmberg, R. Goble, V. Sanchez and D. Quigley, The assessment of radiation exposures in native American communities from nuclear weapons testing in Nevada. Risk Anal. 20, 101-111 (2000).
65. E. S. Gilbert, R. Tarone, A. Bouville and E. Ron, Thyroid cancer rates and I-131 doses from Nevada atmospheric nuclear bomb tests. J. Natl. Cancer Inst. 90, 1654-1660 (1998).
66. E. S. Gilbert, C. E. Land and S. L. Simon, Health effects from fallout. Health Phys. 82, 726-735 (2002).
67. R. E. Lapp, Nuclear-weapons testing fallout and thyroid-disease. J. Am. Med Assoc. 271, 826-826 (1994).
68. J. L. Lyon, Nuclear weapons testing and research efforts to evaluate health effects on exposed populations in the United States. Epidemiology 10, 557-560 (1999).
69. E. Lund and M. R. Galanti, Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: An analysis of birth cohorts. Cancer Causes Control 10, 181-187 (1999).
70. B. S. Richter and H. G. Stockwell, Descriptive study of deaths from cancer associated with residential proximity to the site of underground nuclear detonation. Arch. Environ. Health 53, 109-113 (1998).
71. Z. Zhumadilov, B. I. Gusev, J. Takada, M. Hoshi, A. Kimura, N. Hayakawa and N. Takeichi. Thyroid abnormality trend over time in northeastern regions of Kazakhstan, adjacent to the Semipalatinsk nuclear test site: A case review of pathological findings for 7271 patients. J. Radiat. Res. 41, 35-44 (2000).
72. American Academy of Pediatrics Committee on Environmental Health. Radiation disasters and children. Pediatrics 111, 1455-1466 (2003).
73. J. D. Boice and J. H. Lubin, Occupational and environmental radiation and cancer. Cancer Causes Control 8, 309-322 (1997).
74. R. Doll, Epidemiological evidence of hazard. Radiat. Prot. Dosim. 68, 97-103 (1996).
75. D. L. Fraker, Radiation exposure and other factors that predispose to human thyroid neoplasia. Surg. Clin. N. Am. 75, 365-375 (1995).
76. P. Hall and L. E. Holm. Radiation-associated thyroid cancer-Facts and fiction. Acta Oncol. 37, 325-330 (1998).
77. J. J. Mangano, J. Sherman, C. Chang, A. Dave, E. Feinberg and M. Frimer, Elevated childhood cancer incidence proximate to US nuclear power plants. Arch. Environ. Health 58, 74-82 (2003).
78. C. R. Muirhead, Cancer after nuclear incidents. Occup. Environ. Med. 58, 482-488 (2001).
79. M. F. Prummel, T. Strieder and W. M. Wiersinga, The environment and autoimmune thyroid diseases. Eur. J. Endocrinol. 150, 605-618 (2004).
80. E. Ron, Ionizing radiation and cancer risk: Evidence from epidemiology. Radiat. Res. 150 (Suppl.), S30-S41 (1998).
81. R. Wakeford. The cancer epidemiology of radiation. Oncogene 23, 6404-6428 (2004).
82. B. Mallick, F. O. Hoffman and R. J. Carroll, Semiparametric regression modeling with mixtures of Berkson and classical error, with application to fallout from the Nevada test site. Biometrics 58, 13-20 (2002).
83. D. O. Strain and K. Kopecky. Power analysis of epidemiological studies of radiation-related disease risk when dose estimates are based on a complex dosimetry system with an application to the Hanford Thyroid Disease Study. Radiat. Res. 158, 797-798 (2002).
84. D. O. Strain and K. J. Kopecky, Power and uncertainty analysis of epidemiological studies of radiation-related disease risk in which dose estimates are based on a complex dosimetry system: Some observations. Radiat. Res. 160, 408-417 (2003).